Inhaltspezifische Aktionen

2023

  • Current management of Inherited Retinal Degenerations (IRD) patients in Europe. Results of a 2 years follow-up multinational survey by the Eropean Vision Institute Clinical Research Network - EVICR.net
    Lorenz B, Tavares J, van den Born LI, Marques JP, Pilotto E, Stingl K, Charbel Issa P, Leroux D, Dollfus H, Scholl HPN; EVICR.net study group; ERN-EYE study group
    Ophthalmic Res. 2023 Jan 2
  • Macular hole Delphi consensus statement (MHOST).
    Confalonieri F, Haave H, Binder S, Bober AM, Bragadottir R, Baerland T, Faber R, Forsaa V, Gonzalez-Lopez JJ, Govetto A, Haugstad M, Ivastinovic D, Jenko NČ, Nicoară SD, Kaljurand K, Kozak I, Kvanta A, Lytvynchuk L, Nawrocka ZA, Pajic SP, Petrovič MG, Radecka L, Rehak M, Romano MR, Ruban A, Speckauskas M, Stene-Johansen I, Stranak Z, Thaler A, Thein ASA, Theocharis I, Tomic Z, Yan X, Zekolli M, Zhuri B, Znaor L, Petrovski BE, Kolko M, Lumi X, Petrovski G.
    Acta Ophthalmol. 2023 May 10
  • Current management of patients with RPE65 mutation-associated Inherited Retinal Degenerations (RPE65-IRD) in Europe. Results of a 2 years follow-up multinational survey
    Lorenz B, Tavares J, van den Born LI, Marques JP, Pilotto E, Stingl K, Charbel Issa P, Leroux D, Dollfus H, Scholl HPN
    Ophthalmic Res. 2023 Mar 6
  • Aberrant regeneration in an international registry of patients with 3rd-nerve palsy
    Oke I, Lorenz B, Basiakos S, Gokyigit B, Laurent E, Tsai CB, Orge F, Heidary G, Tjeerd de Faber J, Jeddawi L, Sadiq MA, Strominger M, Dodd MU, Shah AS, Dagi LR, NTSLR3NP Study Group
    Eur J Ophthalmol 2023 Mar
  • Combining CNNs and Markov-like Models for Facial Landmark Detection with Spatial Consistency Estimates
    Gdoura A, Degünther M, Lorenz B, Effland A
    Imaging 2023 May 22;9(5):104
  • Worldwide outcomes of nasal transposition of the split lateral rectus muscle for strabismus associated with 3rd-nerve palsy
    Shah AS, Dodd MU, Gokyigit B, Lorenz B, Laurent E, Sadiq MAA, Tsai CB, Gravier N, Goberville M, Basiakos S, Zurakowski D, Dagi LR, NTSLR3NP Study Group
    Br J Opthalmol 2023 May;107(5):725-732
  • Bloß eine Trochlearisparese?
    Starosta DA, Gräf M
    Die Ophthalmologie 2023 Jan; 1-4
  • Rehabilitation surgery for oculomotor nerve palsy
    Graef M, Starosta DA, Hausmann A
    Ophthalmologie 2023 Feb
  • High-dose medialis recession in latent nystagmus
    Gräf M, Seliametova L, Hausmann A
    Ophthalmologie 2023, Jun;120(6):628-632
  • Retinal Pigment Epithelium Cell Development: Extrapolating Basic  Biology to Sterm Cell Research
    Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Faura G, Eide L, Znaor L, Erceg S, Stieger K, Motlik J, Bharti K, Petrovski G
    Biomedicines. 2023 Jan 23;11(2):310
  • Change in the age spectrum in strabismus surgery
    Starosta DA, Gräf M
    Ophthalmologie 2023 Nov
  • Rapid and Reliable Quantification of Prime Editing Targeting Within the Porcine ABCA4 Gene Using a Bioluminescence Resonance Energy Tranfer-Based Sensor
    Wimmer T, Sawinski H, Urban AM, Motlik J, Stieger K
    Nucleic Acid Ther 2023 Mar
  • 10 years of screening for retinopathy of prematurity (2009 - 2019): Results analysis of two German level-1 neonatal intensive care units (NICUs) with university on-site screening and a telemedical approach in the non-university NICU
    Busik V, Lorenz G, Mais C, Jäger M, Friedburg C, Andreassi-Darida M, Ehrhardt H, Hubert M
  • Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium In Vivo Delivery
    Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Sharma R, Faura G, Eide L, Shanker Verma R, Znaor L, Erceg S, Stieger K, Motlik J, Petrovski G, Bharti K
    Stem Cells Transl Med. 2023 Aug 16;12(8):536-552
  • Comments on: Internal Limiting Membrane Peeling and Gas Tamponade for Full-Thickness Macular Holes of Different Etiology - Is It Still Relevant? (Rsponse to Letter).
    Ruban A, Petrovski BÉ, Petrovski G, Lytvynchuk LM
    Clin Ophthalmol 2023 Jan
  • Biomacromolecular Profile in Human Primary Retinal Pigment Epithelial Cels-A Study of Oxdidative Stress and Autophagy by Syncchrotron-based FTIR Microspectroscopy
    Josifovska N, Andjelic S, Lytvycnuk L, Lumi X, Dudčić T, Petrovski G
    Biomedicines 2023 Jan 21;11(2):300
  • Current practice in the treatment of epithelial and melanocytic tumors with Interferon-alpha 2b: a survey among tertiary eye centers in Germany
    Jiang J, Böhringer D, Auw-Hädrch C Maier PC, Barth T Eter N, Fuest M, Geerling G, Heindl MH, Herwig-Carl M, Meller D, Mueller A, Pfeiffer N, Rehak M, Schargus M, Seitz B, Spitzer M, Stahl A, Süsskind D, van Oterendorp, Wagner FM, Westekemper H, Ziemssen F, Reinhard T
    Klin Mon Augenheilk 2023 Feb
  • Participation in a clinical trial - Is that somethin for me? (Video article)
    Lorenz K, Böhringer D, Wilhelm B, Arbeitsgemeinschft DOG Klinische Studienzentren
    Ophthalmologie 2023 April
  • Different responses of the MIO‑M1 Mueller cell line to angiotensin II under hyperglycemic or hypoxic conditions
    Beuse A, Deissler HL, Hollborn M, Unterlauft JD, Busch C, Rehak M
    Biomed Rep. 2023; 19(3):62
  • Epidemiological impact of the COVID-19 pandemic on enucleation cases in Germany
    Carlos Reyna E, Rehak M, Alfaar AS
    Ophthalmology 2023 Nov;120(11):1117-1121
  • Real-world experience with Voretigene Neparvovec gene augmentation therapy in RPE65-mutation associated inherited retinal degeneration
    Lorenz B, Künzel SH, Preising MN, Scholz JP, Chang P, Holz FG, Herrmann P.
    Ophthalmology. 2023 Sep 11:S0161-6420(23)00631-0
  • Prospective noninterventional BLUE SKY study evaluating the  efficacy of brolucizumab in treatment-

    naïve and previouslytreated patients with neovasular AMD
    Faatz H, Feltgen N, Gutfleisch M, Heimes-Bussmann B, Krohne TU, Liakopoulos S, Liegl R, Lommatzsch, Mussinghoff P, Rehak M, Schmitz-Valckenberg S, Spital G, Stanzel B, Ziemssen F, Hägele B, Junkes C, Porstner M, Vögeler J, Gmeiner B, Pauleikof D
    Ophthalmologie 2023 Mar;120(3):294-30